Last updated: 2026-09-16 12:18:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Natural Alternatives International Inc. (NAII) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $1,98, with a market capitalisation of $12,30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,90 to $4,96. This page covers its latest market performance, valuation, price trends and company information.
$12,30M | |
$1,98 | |
$19,93 | |
$1,90 | |
$1,96 | |
1,53K | |
42,32K | |
-- | |
$4,96 | |
$1,90 | |
-- | |
-- |
Natural Alternatives International Inc. (NAII) is trading at $2,02 in pre-market trading as of 2026-09-15 20:11:00, up 3,06% ($0,06) from the previous close of $1,96
Pre-market trading shows how investors are pricing NAII before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Natural Alternatives International Inc. (NAII) moved from $2,08 to $1,98, representing a decline of 4,81% ($0,10).
The stock traded between $1,90 and $2,20 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 12,06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2,6%
NAII is currently trading at $1,98, placing it 2,6% of the way from its 52-week low of $1,90 to its 52-week high of $4,96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 234 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Natural Alternatives International Inc. (NAII) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.